Cancer remains one of the most complex diseases, with its diverse molecular profiles and cellular compositions posing ...

A study published in Science Advances shares new insights into how two of the most common types of chimeric antigen receptor ...

Cancer is a disease of the genome, according to Dr. Elli Papaemmanuil, computational oncologist at MSK. By looking at the ...

The fight against cancer often begins with uncovering hidden players, and a recent study reveals one such key player: an ...

The Perlmutter Cancer Center at New York City-based NYU Langone Health recently launched its new Center for Molecular Oncology, naming Shridar Ganesan, MD, PhD, as director. The center will manage, ...

Our cell biology researchers collaborate with molecular ... Many of our scientists study the cellular, molecular and genetic changes that trigger cancer and its progression. These studies may reveal ...

A groundbreaking study from Baylor College of Medicine explores how two types of CAR T cells target cancer, shedding light on ...

Fred Hutch grew from a regional cancer center into a world-class biomedical research and clinical care institution known for ...

They kill cancer cells consistently over a long period. We need to understand what's happening at the molecular level so we can engineer ... We need to adapt our tools to the biology of the disease.

The fight against cancer often begins with uncovering hidden players, and this study reveals one such key player: an ...

A new paper by a team of Concordia researchers from the departments of Biology and Physics proposes a novel method of ...